谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A CD33-Deleted Allograft (Trem-Cel) Enables Post-Hematopoietic Cell Transplant (HCT) Maintenance Dosing of Gemtuzumab Ozogamicin (GO) with Therapeutic Levels of Drug Exposure and Low Hematologic and Hepatic Toxicity in Patients with High-Risk Acute Myeloid Leukemia (AML)

John F. DiPersio,Guenther Koehne,Nirali N. Shah,Lea Bernard,Hyung C Suh,Divya Koura,Miguel Angel Perales,Roni Tamari, Muhammad Umair Mushtaq,Joseph E. Maakaron,Michael R. Loken, Darren A Stanizzi, Melissa M. Lee-Sundlov, Sanjana Thosar,Sharon L Hyzy,Glen D Raffel,Brenda W Cooper

Blood（2024）

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要